REQUEST A DEMO
Total
USD $0.00
Search more companies

Henan Taloph Pharmaceutical Stock Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Henan Taloph Pharmaceutical Stock Co.,Ltd Profile Updated: November 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

The company is a modern pharmaceutical company integrated of production, management, scientific research, specialized in Chinese medicine products. The company has oral liquid, tablets, capsules, fluids, materials and other dosage forms of 100 kinds of products, formed Chinese medicine series products of clearing heat-toxicity which is mainly in Shuanghuanglian, Shuangjinlian mixture and oral liquid of clearing heat-toxicity, series of anti-bacterial and anti-inflammatory which is mainly in raw material, small needle and infusion of categoryⅡnew drug, maculate pazufloxacin and other western medicine products, such as the old people use which is mainly in Phenoxybenzamine and Hyperfine. The company also is recognized as the key high-tech enterprise of National Torch-planning Project.

Headquarters
No. 8, Jinsuo Road, High-tech Industrial Development Zone, Zhengzhou City, Henan Province
Zhengzhou; Henan; Postal Code: 450001

Contact Details: Purchase the Henan Taloph Pharmaceutical Stock Co.,Ltd report to view the information.

Website: http://www.taloph.com

Basic Information
Total Employees:
Purchase the Henan Taloph Pharmaceutical Stock Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Henan Taloph Pharmaceutical Stock Co.,Ltd report to view the information.
Registered Capital:
Purchase the Henan Taloph Pharmaceutical Stock Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Henan Taloph Pharmaceutical Stock Co.,Ltd report to view the information.
Incorporation Date:
August 31, 1998
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
14.37%
Purchase this report to view the information.
8.71%
Purchase this report to view the information.
2.24%
Purchase this report to view the information.
1.09%
Purchase this report to view the information.
0.87%
Subsidiaries
Beijing New Leading Pharmaceutical Technology Development Co., Ltd.
Chongqing Benzene Cube Pharmaceutical Technology Co., Ltd.
Hangzhou Derunquan Biopharmaceutical Co., Ltd
Company Performance
Financial values in the chart are available after Henan Taloph Pharmaceutical Stock Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-7.08%
Total operating revenue
-6.37%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
11.54%
Total equity
8.58%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
9.76%
Quick Ratio
0.01%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?